INVESTORS
OVERVIEW

We invite all current and prospective shareholders, partners, and other interested parties to browse our website to learn more about the exciting developments at our Company.

 

Novoheart is committed to providing state-of-the-art stem cell and bioengineering approaches to revolutionize drug discovery, while balancing with economic development of the Company and enhance returns to shareholders.

STOCK INFORMATION
CORPORATE GOVERNANCE
Management Team
Board of Directors
FAQS

Where are Novoheart shares traded?
Novoheart’s shares trade on Toronto Venture Stock Exchange (TSXV) under ticker NVH and OTC in Germany under ticker 3NH.

How do I buy or sell Novoheart shares?
Shares must be purchased on the open market through a bank, broker or online trading platform. Novoheart trades under NVH in Canada and 3NH in Germany.

How can I obtain a copy of Novoheart’s annual and quarterly reports?
Novoheart’s filings are available from the Canadian System for Electronic Document Analysis and Retrieval (“SEDAR”) at www.sedar.com.

When is Novoheart’s next Annual General Meeting?
February 2018

How to vote my shares?
Unless you have otherwise opted out, you will receive a Form of Proxy in the mail prior to the Annual General Meeting. The form will include detailed instructions and methods of voting. Please ensure your vote is cast before the deadline on the form.

How do I find Novoheart’s current share price?
Novoheart’s current share price can be found on TMX Money website: https://web.tmxmoney.com/quote.php?qm_symbol=NVH. You may also find out current share price on our website: www.novoheart.com/global/investors.


Who do I contact about share transfers, lost share certificates, dividend cheques or address change?

Please contact Novoheart’s Transfer Agent:

TSX TRUST COMPANY LIMTED
Toll Free: 1 866 393-4891
Tel: (416) 361-0930
Fax: (416) 361-0470
301-100 Adelaide Street West, 
Toronto, ON, M5H 4H1, Canada

Email: TMXEInvestorServices@tmx.com


Who is Novoheart’s independent auditor?

Novoheart’s auditor is:

MNP LLC
Toll Free: 1 877 688-8408
Tel: (604) 685-8408
Fax: (604) 685-8594
Suite 2200, 1021 West Hastings St,  
Vancouver, BC, V6E 0C3, Canada
Website: MNP.CA
 

When is Novoheart’s fiscal year end?
Novoheart’s fiscal year ends on June 30th.
 

Where can I find Novoheart’s regulatory filings?
Novoheart’s financial statements can be found by searching through www.sedar.com. They can also be found here: Financial Information.


Does Novoheart have analyst calls?
Novoheart does not conduct analyst calls which are open to public at this time. If you have questions, please email investors@novoheart.com

How do I do research on Novoheart?
Research on Novoheart Holdings Inc. can be done through www.sedar.com


Any other question not found above? Please contact us here.

INVESTOR CONTACT

Investor inquiries can be directed to:

Babak Pedram
President
Virtus Advisory Group Inc.

100 King West, Suite 5600,
Toronto, ON, M5X 1C9,
Canada
T: 416-644-5081 | C: 416-995-8651 | F: 416-644-8801
Email: bpedram@virtusadvisory.com